Data processing: financial – business practice – management – or co – Automated electrical financial or business practice or... – Health care management
Reexamination Certificate
2001-10-10
2008-10-28
Smith, Jeffrey A. (Department: 3626)
Data processing: financial, business practice, management, or co
Automated electrical financial or business practice or...
Health care management
C705S002000, C707S793000, C707S793000, C717S135000, C600S300000, C704S009000
Reexamination Certificate
active
07444293
ABSTRACT:
Structure and methodology for reducing risk of protocol ambiguities that could lead to operational failures in the conduct of clinical trials. Roughly described, an analyst encodes the features of a protocol into a highly structured, formal model created specifically to capture issues that tend to cause operational difficulties. The process forces the analyst to look for specific parameters in the text version of the protocol. The system creates a database of the protocol as encoded, and can display the protocol schema as a graphical network of protocol events and temporal links. In one aspect, the database includes an object class into which an analyst encodes descriptions of operational uncertainties. The system can display the network in graphical-visual form, with a human-perceptible indication of objects that have operational uncertainties associated therewith. Advantageously, the formal protocol model includes slots for encoding temporal constraints among protocol events.
REFERENCES:
patent: 5812983 (1998-09-01), Kumagai
patent: 5812984 (1998-09-01), Goltra
patent: 5832449 (1998-11-01), Cunningham
patent: 5867821 (1999-02-01), Ballantyne et al.
patent: 5991731 (1999-11-01), Colon et al.
patent: 6055494 (2000-04-01), Friedman
patent: 6081786 (2000-06-01), Barry et al.
patent: 6081809 (2000-06-01), Kumagai
patent: 6108635 (2000-08-01), Herren et al.
patent: 6196970 (2001-03-01), Brown
patent: 7054823 (2006-05-01), Briegs et al.
patent: 2002/0016530 (2002-02-01), Brown
“Decision support for clinical trial eligibility determination in breast cancer”; L Ohno-Machado, SJ Wang, P Mar, AA Boxwala-Proc AMIA Symp, 1999.
“EON: A component-based approach to automation of protocol-directed therapy”; MA Musen, SW Tu, AK Das, Y Shahar-J Am Med Inform Assoc., 1996.
“Unitized data system: Anew formalism for encoding and presenting data from the scientific research literature”; DP Fan, JM Curtsinger, L Johnson, S Kalkhar- Journal of the American Society for Information Science, 1992.
Brown, et al., U.S. Appl. No. 09/974,781, filed Oct. 10, 2001, entitled Leveraging Interaction with a Community of Individuals. 84 pages.
DataEdge LLC. Indexes of Clinical Study Complexity, 1993-1999. In: Mathieu MP, editor. Parexel's Pharmaceutical R&D Statistical Sourcebook 2000. Waltham, MA: Parexel International Corp; 2000. p. 66.
DataEdge LLC. Indexes of Clinical Trial Costs Per Patient, 1993-1999. In: Mathieu MP, editor. Parexel's Pharmaceutical R&D Statistical Sourcebook 2000. Waltham, MA: Parexel International Corp; 2000. p. 67.
Grosso W. E. et al.; “Knowledge Modeling at the Millennium (The Design and Evolution of Protégé-2000),” SMI Report No. SMI-1999-0801 (1999), available at http://smi-web.stanford.edu/ pubs/SMI—Abstracts/SMI-1999-0801.html, visited Jan. 1, 2000.
Holford N. H. G.; Kimko H. C.; Monteleone J. P. R., and Peck C. C.; “Simulation of Clinical Trials,” Annu. Rev. Pharmacol. Toxicol. 2000, 40:209-34, 2000, Annual Reviews.
“ICH Harmonised Tripartite Guideline: General Considerations for Clinical Trials,” International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use recommended for adoption on Jul. 17, 1997, URL: www.ifpma.org/ich5c.html, Accessed: Aug. 31, 2001.
“ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice,” International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use recommended for adoption on May 1, 1996, URL: www.ifphma.org/ich5e.html, Accessed: Aug. 31, 2001.
Kroll J. A.; De Bruin A.; Getz K.; Eschmann K.; and Zisson S.; “Study Conduct Delays are Getting Worse,” In: Kroll JA, editor. An Industry In Evolution. Second ed. Boston, MA: CenterWatch; 1999. p. 99.
Musen M. A.; “Domain Ontologies in Software Engineering: Use of Protégé with the EON Architecture,” Methods of Information in Medicine, F.K. Schattauer Verlagsgesellschaft mbH (1998); 37:540-50.
Musen M. A.; Gennari J. H.; Eriksson H.; Tu S. W., and Puerta A. R.; Protégé-II: Computer Support for Development of Intelligent Systems from Libraries of Components, MEDINFO 95 Proceedings, R. A. Greenes et al. (editors); 8(1):766-70.
Musen M.A.; Rohn J. A.; Fagan L. M.; and Shortliffe E. H.; “Knowledge Engineering for a Clinical Trial Advice System: Uncovering Errors in Protocol Specification,” Report KSL-85-51, Proceedings AAMSI Congress 1986 (Levy, A.H. and Williams, B.T., eds.), pp. 24-27, Anaheim CA, May 1986.
Sheiner L. B. and Steimer J. L.; “Pharmacokinetic/Pharmacodynamic Modeling in Drug Development,” Annu. Rev. Pharmacol. Toxicol. 2000. 40:67-95, 2000, Annual Reviews.
Wampler S., “Tackling Protocol Complexity,” Good Clinical Practice Journal, 2000; vol. 7, No. 2: pp. 6-8.
Broverman Carol A.
Kahn Michael G.
Kingdon Kelly A.
Cobanoglu Dilek B
FastTrack Systems, Inc.
Haynes Beffel & Wolfeld LLP
Smith Jeffrey A.
Wolfeld Warren S.
LandOfFree
Protocol disambiguation using a model-based methodology does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protocol disambiguation using a model-based methodology, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protocol disambiguation using a model-based methodology will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4019215